Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Oct 25;31(45):5250-5.
doi: 10.1016/j.vaccine.2013.08.051. Epub 2013 Sep 5.

Immunisation with ID83 fusion protein induces antigen-specific cell mediated and humoral immune responses in cattle

Affiliations

Immunisation with ID83 fusion protein induces antigen-specific cell mediated and humoral immune responses in cattle

Gareth J Jones et al. Vaccine. .

Abstract

In this study we have investigated the potential of mycobacterial proteins as candidate subunit vaccines for bovine tuberculosis. In addition, we have explored the use of TLR-ligands as potential adjuvants in cattle. In vitro screening assays with whole blood from Mycobacterium bovis-infected and BCG-vaccinated cattle demonstrated that fusion protein constructs were most commonly recognised, and the ID83 fusion protein was selected for further immunisation studies. Furthermore, glucopyranosyl lipid A (GLA) and resiquimod (R848), agonists for TLR4 and TLR7/8 respectively, stimulated cytokine production (IL-12, TNF-α, MIP-1β and IL-10) in bovine dendritic cell cultures, and these were formulated as novel oil-in-water emulsions (GLA-SE and R848-SE) for immunisation studies. Immunisation with ID83 in a water-in-oil emulsion adjuvant (ISA70) induced both cell mediated and humoral immune responses, as characterised by antigen-specific IFN-γ production, cell proliferation, IgG1 and IgG2 antibody production. In comparison, ID83 immunisation with the novel adjuvants induced weaker (ID83/R848-SE) or no (ID83/GLA-SE) antigen-specific IFN-γ production and cell proliferation. However, both did induce ID83-specific antibody production, which was restricted to IgG1 antibody isotype. Overall, these results provide encouraging preliminary data for the further development of ID83 in vaccine strategies for bovine TB.

Keywords: Adjuvants; Bovine tuberculosis; Mycobacterium bovis; Vaccine.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Selection of the ID83 fusion protein for vaccination studies
(A) Responder frequency of 22 TB reactor animals to 54 recombinant proteins from the IDRI protein repository. Filled bars denote responses to novel IDRI fusion proteins. (B) Responder frequency of 22 TB reactor and between 5 and 9 (depending on the protein) BCG vaccinated animals to the 6 IDRI fusion proteins. In both graphs, the responder frequency is based on IFN-γ production as the readout.
Figure 2
Figure 2. Cytokine production by bovine MDDC following stimulation with GLA and R848
Bovine MDDC were cultured for 24 hours in the presence of increasing concentrations of GLA, R848 or a mixture of GLA and R848. Quantification of (A) TNF-α, (B) MIP-1β, (C) IL-10 and (D) IL-12 was performed using a cytokine multiplex assay. Data shown is representative of two experiments.
Figure 3
Figure 3. Immunisation with ID83 induces cellular and humoral immune responses
Cattle (four per group) were immunised at week 0 and week 4 as detailed in the material and methods. Blood samples were taken at 2 weekly intervals for assessment of (A) ID83-specific whole blood IFN-γ production, (B) ID83-specific PBMC proliferation, and (C) ID83-specific IgG serum antibody levels. Median responses for each group are plotted. * p<0.05, ** p<0.01, *** p<0.001, nonparametric ANOVA with Dunn’s Multiple Comparison Test (versus the PBS control group at each time point).
Figure 4
Figure 4. Immunisation with ID83/ISA70 induces production of ID83-speficic IgG2 serum antibodies
Cattle (four per group) were immunised at week 0 and week 4 as detailed in the material and methods, and blood samples taken at 2 weekly intervals for assessment of (A) ID83-specific IgG1, or (B) ID83-specific IgG2 serum antibody levels. Median responses for each group are plotted. * p<0.05, ** p<0.01, *** p<0.001, nonparametric ANOVA with Dunn’s Multiple Comparison Test (versus the PBS control group at each time point).

References

    1. DEFRA. The UK Chief Veterinary Officer’s 2009 report on animal health and welfare. 2010 http://wwwdefragovuk/corporate/about/who/cvo/documents/2009reportpdf.
    1. Skinner MA, Wedlock DN, de Lisle GW, Cooke MM, Tascon RE, Ferraz JC, et al. The order of prime-boost vaccination of neonatal calves with Mycobacterium bovis BCG and a DNA vaccine encoding mycobacterial proteins Hsp65, Hsp70, and Apa is not critical for enhancing protection against bovine tuberculosis. Infect Immun. 2005;73:4441–4. - PMC - PubMed
    1. Vordermeier HM, Villarreal-Ramos B, Cockle PJ, McAulay M, Rhodes SG, Thacker T, et al. Viral booster vaccines improve Mycobacterium bovis BCG-induced protection against bovine tuberculosis. Infect Immun. 2009;77:3364–73. - PMC - PubMed
    1. Wedlock DN, Denis M, Skinner MA, Koach J, de Lisle GW, Vordermeier HM, et al. Vaccination of cattle with a CpG oligodeoxynucleotide-formulated mycobacterial protein vaccine and Mycobacterium bovis BCG induces levels of protection against bovine tuberculosis superior to those induced by vaccination with BCG alone. Infect Immun. 2005;73:3540–6. - PMC - PubMed
    1. O’Hagan DT, Rappuoli R. Novel approaches to vaccine delivery. Pharmaceutical research. 2004;21:1519–30. - PMC - PubMed

Publication types

MeSH terms